---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-007597"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2025-02-19T23:59:59+00:00"
generated_at: "2026-05-26T12:33:15.793599+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals enters advisory consulting agreement and receives $120K from warrant exercise

## Summary
- Issued 200,000 restricted shares to 6330 Investment & Consulting for 12-month strategic advisory services.
- Received $120,000 aggregate exercise price for 80,000 shares from a warrant holder at $1.50 per share.
- Consultant will provide introductions for strategic partners and M&A opportunities; estimated 10 hours/week.
- Shares issued under Section 4(a)(2) exemption; no public offering or underwriting.

## SEC filing metadata
- accession: 0001493152-25-007597
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2025-02-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315225007597/0001493152-25-007597-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315225007597/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-007597
- JSON: https://secwatch.observer/filing/0001493152-25-007597.json
- Plain text: https://secwatch.observer/filing/0001493152-25-007597.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.